KCM
IMCR icon

Kynam Capital Management’s Immunocore IMCR Stock Holding History

Kynam Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.7M Buy
1,375,000
+490,063
+55% +$14.5M 2.41% 15
2026
Q1 		$26.7M Buy
884,937
+28,475
+3% +$921K 1.65% 17
2025
Q4 		$29.7M Sell
856,462
-152,805
-15% -$5.39M 1.9% 15
2025
Q3 		$36.7M Buy
1,009,267
+33,000
+3% +$1.12M 2.73% 10
2025
Q2 		$30.6M Sell
976,267
-719,309
-42% -$22.3M 3.3% 10
2025
Q1 		$50.3M Buy
1,695,576
+470,000
+38% +$14.1M 4.23% 10
2024
Q4 		$36.2M Buy
+1,225,576
New +$38.7M 2.14% 14

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Kynam Capital Management's IMCR Position: Q2 2026 in Review

Kynam Capital Management increased its Immunocore (IMCR) stake by 55% in Q2 2026, buying an estimated $14.5M and bringing the position to 1,375,000 shares worth $43.7M. The position accounts for 2.41% of the portfolio, ranked #15.

Kynam Capital Management first reported a position in IMCR in Q4 2024 and has held it in 7 quarters since. The position peaked at $50.3M in Q1 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Kynam Capital Management held 1,375,000 shares of Immunocore worth $43.7M as of Q2 2026.
  • Kynam Capital Management bought 490,063 Immunocore shares in Q2 2026, an estimated $14.5M.
  • Immunocore made up 2.41% of Kynam Capital Management's portfolio in Q2 2026, its #15 holding.
  • Kynam Capital Management first reported a position in Immunocore in Q4 2024 and has held it in 7 quarters since.
  • Kynam Capital Management's Immunocore position peaked at $50.3M in Q1 2025.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Kynam Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.